|
HNRNPU expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.818900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.74910000000561E-05 |
| Normal-vs-Stage2 |
2.879000E-03 |
| Normal-vs-Stage3 |
3.650000E-01 |
| Normal-vs-Stage4 |
1.927390E-01 |
| Stage1-vs-Stage2 |
9.529000E-01 |
| Stage1-vs-Stage3 |
5.035900E-02 |
| Stage1-vs-Stage4 |
3.578000E-01 |
| Stage2-vs-Stage3 |
1.833040E-01 |
| Stage2-vs-Stage4 |
4.031000E-01 |
| Stage3-vs-Stage4 |
7.570000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.389300E-04 |
| Normal-vs-AfricanAmerican |
1.560380E-03 |
| Normal-vs-Asian |
6.110500E-02 |
| Caucasian-vs-AfricanAmerican |
6.491600E-01 |
| Caucasian-vs-Asian |
8.091800E-01 |
| AfricanAmerican-vs-Asian |
9.192800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.90547999999735E-05 |
| Normal-vs-Female |
2.972400E-01 |
| Male-vs-Female |
5.952600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.196600E-03 |
| Normal-vs-Extreme_Weight |
4.00680000001152E-06 |
| Normal-vs-Obese |
5.377800E-02 |
| Normal-vs-Extreme_Obese |
3.201600E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.873600E-01 |
| Normal_Weight-vs-Obese |
2.683800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.229800E-01 |
| Extreme_Weight-vs-Obese |
1.312220E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.488000E-01 |
| Obese-vs-Extreme_Obese |
1.950410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.095800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.638700E-03 |
| Normal-vs-Age(61-80Yrs) |
3.70499999999829E-05 |
| Normal-vs-Age(81-100Yrs) |
6.350700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.322200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.359600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.934300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.760500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.016210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.612200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.598300E-04 |
| Normal-VS-Type2 PRCC |
2.440800E-03 |
| Normal-VS-KIRP CIMP |
8.481800E-01 |
| Normal-VS-Unclassified PRCC |
4.136100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.396000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.065800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.955200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.063440E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.187400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.741630E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.6214999999663E-06 |
| Normal-vs-N1 |
3.351400E-01 |
| Normal-vs-N2 |
8.804400E-02 |
| N0-vs-N1 |
6.983600E-04 |
| N0-vs-N2 |
6.484400E-01 |
| N1-vs-N2 |
1.921220E-01 |
|
|
